GSK(GSK)
GSK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $34.03B | $35.78B | $36.95B | $38.22B | $37.62B |
| Low | $33.79B | $33.50B | $35.80B | $37.04B | $36.45B |
| High | $34.25B | $36.90B | $38.05B | $39.36B | $38.74B |
| EBITDA Avg | $11.40B | $11.99B | $12.38B | $12.80B | $12.60B |
| Low | $11.32B | $11.22B | $11.99B | $12.41B | $12.21B |
| High | $11.47B | $12.36B | $12.74B | $13.18B | $12.98B |
| EBIT Avg | $9.33B | $9.81B | $10.13B | $10.48B | $10.32B |
| Low | $9.27B | $9.19B | $9.82B | $10.16B | $10.00B |
| High | $9.39B | $10.12B | $10.43B | $10.79B | $10.62B |
| Net Income Avg | $3.67B | $4.07B | $4.36B | $4.51B | $4.58B |
| Low | $3.53B | $3.81B | $3.99B | $4.33B | $4.40B |
| High | $3.80B | $4.32B | $4.73B | $4.69B | $4.76B |
| EPS Avg | $3.58 | $3.92 | $4.13 | $4.38 | $4.45 |
| Low | $3.43 | $3.71 | $3.88 | $4.21 | $4.27 |
| High | $3.69 | $4.20 | $4.60 | $4.55 | $4.62 |
| Analysts (Rev / EPS) | 12 / 5 | 13 / 6 | 16 / 8 | 15 / 6 | 15 / 6 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $8.92B | $8.98B | $7.88B | $8.43B | $9.11B | $9.17B |
| Low | $8.48B | $8.64B | $7.58B | $8.11B | $8.77B | $8.82B |
| High | $9.34B | $9.28B | $8.15B | $8.72B | $9.42B | $9.48B |
| EBITDA Avg | $2.99B | $3.01B | $2.64B | $2.83B | $3.05B | $3.07B |
| Low | $2.84B | $2.89B | $2.54B | $2.72B | $2.94B | $2.95B |
| High | $3.13B | $3.11B | $2.73B | $2.92B | $3.16B | $3.18B |
| EBIT Avg | $2.45B | $2.46B | $2.16B | $2.31B | $2.50B | $2.51B |
| Low | $2.33B | $2.37B | $2.08B | $2.23B | $2.40B | $2.42B |
| High | $2.56B | $2.55B | $2.23B | $2.39B | $2.59B | $2.60B |
| Net Income Avg | $2.17B | $1.14B | $1.92B | $1.91B | $2.33B | $1.13B |
| Low | $2.04B | $1.08B | $1.83B | $1.81B | $2.21B | $1.07B |
| High | $2.26B | $1.19B | $2.01B | $1.99B | $2.43B | $1.18B |
| EPS Avg | $1.07 | $0.56 | $0.94 | $0.94 | $1.14 | $0.55 |
| Low | $1.00 | $0.53 | $0.90 | $0.89 | $1.09 | $0.53 |
| High | $1.11 | $0.58 | $0.98 | $0.98 | $1.19 | $0.58 |
| Analysts (Rev / EPS) | 5 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |